I’ve always said that the more you dig here the better it gets.
Here’s everything you need to know for now but this will be a multi product biotech doing billions in revenue. It will have multiple trials on various illnesses and their cures. I believe there will be multiple partnerships like the TMO deal and that this will be worth billions of dollars.
Adpt revenue multiple 100x Pred revenue multiple 12x
Adpt on nasdaq Pred on way to nasdaq
Pps adpt $39 Pps pred $1-60
Number of products adpt 1 Number of products pred multiple
Adpt partners Microsoft Pred IQVIA and ThermoFisher
Employees adpt 300 Employees pred 200 and growing
Only difference is time. It’s going to happen
Here’s everything else on pred
I know there’s a lot of excitement with this “big hitter” going after Hindenburg and the “shorts” and that’s great but it doesn’t help you today other than making you feel a bit better and having a white knight ride to your aid. It’s not important. The important things are listed below and the company fundamentals are continuing to improve.
One of our would be experts has pulled distorted financials out to validate his doomsday scenario. The company is surrounded by deep pockets, has never gone into the market for money and is cash flowing with increasing revenues, building out new facilities and hiring world class team.
A example of real world values in this field is adpt which just did an iPo and has a $6B market cap and a $40 share price. It has less revenue, relies on one product and the team is a shadow of the team in pred.It has about 10% of what pred has! This will be proven out.
Everyone would have loved to sell at $6-90 and buy back yesterday but 1% do that. You are not stupid. It’s the way it is. The company is legit, the people are legit and the relationships are legit. Don’t get caught in the short sighted daily game. Do you’re own homework, I’ve taken a lot of the work out of it for you below. It’s easy to fool one big guy into joining you but you can’t fool the best of the best in the medical world, pfe, tmo, as well as the best Kesha’s minds Wilson sonsini (their partner joined the board) , the top Nasdaq guys, form 10 through the second and also zacks did a full review https://s1.q4cdn.com/460208960/files/News/2019/Zacks_SCR_Research_06112019_PRED_Vandermosten.pdf
This will end and recover and we still have one of the best companies on the street and this will be proven out Here’s the only thing that matters
The U.S. Cord Blood Banking (CBB) services market was valued over USD 17.2 billion in 2016 and is expected to reach over USD 49.09 billion at CAGR of around 12.2% during the forecast period. High awareness regarding benefits of cord blood (CB), tissue, and placenta storage coupled with increasing number of service providers offering services at competitive prices are the factors driving the market growth.
Here’s my 2 cents for what’s it’s worth Classic bear raid and attack piece by this Hindenburg group that clearly states he’s short! “Hindenburg Research (possibly along with or through our members, partners, affiliates, employees, and/or consultants) along with our clients and/or investors has a short position in all stocks (and/or options of the stock) covered herein, and therefore stands to realize significant gains in the event that the price of any stock covered herein declines. ”
Look at the logic here, the article was totally biased and used info that was completely incorrect to spook people and it worked.
It’s hard to look at but this will all wash out and company will uplist and get it’s true value point when the big boys come in. Right now it’s easy to scare retail investors and this was their last chance and they took it. It’s shitty and unfair but it’s the way the market works.
As I always say, do your homework and know what you own